The effects of acute, chronic and withdrawn progesterone in male and female Mongolian gerbils (Meriones unguiculatus) in two tests of anxiety

Behavioural Brain Research

Volumn 207, Issue 2, 2010, Pages 490-499

  Starkey, Nicola Jayne ^a   Bridges, Nikola Jane ^b  

^a UNIVERSITY OF WAIKATO   (New Zealand)

^b UNIVERSITY OF CENTRAL LANCASHIRE   (United Kingdom)

Author keywords

Anxiety; Black white box; Elevated plus maze; Gerbil; Light dark transition; Neuroactive steroid; Progesterone; Sex differences

Indexed keywords

PROGESTERONE;

ACUTE DRUG ADMINISTRATION; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BEHAVIOR CHANGE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG RESPONSE; EXPLORATORY BEHAVIOR; FEMALE; GERBIL; LIGHT DARK CYCLE; LOCOMOTION; MALE; MAZE TEST; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SEX DIFFERENCE; SINGLE DRUG DOSE; TASK PERFORMANCE; TRANQUILIZING ACTIVITY;

ANALYSIS OF VARIANCE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; EXPLORATORY BEHAVIOR; FEMALE; GERBILLINAE; MALE; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; PROGESTERONE; RANDOM ALLOCATION; SEX CHARACTERISTICS; SUBSTANCE WITHDRAWAL SYNDROME; TIME FACTORS;

EID: 74449091640     PISSN: 01664328     EISSN: 18727549     Source Type: Journal    
DOI: 10.1016/j.bbr.2009.10.039     Document Type: Article

References (87)

1. Ǻgren G. Pair formation in the Mongolian gerbil. Anim Behav 32 (1984) 528-535
2. Ågren G. Territoriality, co-operation and resource priority: hoarding in the Mongolian gerbil. Anim Behav 37 (1989) 28-32
3. Ågren G., Zhou Q., and Zhong W. Ecology & social behaviour of Mongolian Gerbils, Meriones unguiculatus, at Xilinhot, Inner Mongolia, China. Anim Behav 37 (1989) 11-27
4. Amin Z., Mason G.F., Cavus I., Krystal J.H., Rothman D.L., and Epperson C.N. The interaction of neuroactive steroid and GABA in the development of neuropsychiatric disorders in women. Pharmacol Biochem Behav 84 (2006) 635-643
5. Anseloni V.Z., and Brandão M.L. Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze. Behav Pharmacol 8 (1997) 533-540
6. Auger C.J., and Forbes-Lorman R.M. Progestin receptor mediated reduction of anxiety-like behavior in male rats. PLoS One 3 11 (2008) e3606 10.1371/journal.pone.0003606
7. Beckley E.H., and Finn D.A. Inhibition of progesterone metabolism mimics the effect of progesterone withdrawal on forced swim test immobility. Pharmacol Biochem Behav 87 (2007) 412-419
8. A receptor. Nat Rev Neurosci 6 (2005) 565-575
9. Beresford I.J., Birch P.J., Hagan R.M., and Ireland S.J. Investigation into species variants in tachykinin NK1 receptors by use of the non peptide antagonist, CP-96,345. Br J Pharmacol 104 (1991) 292-293
10. A receptor. Brain Res 561 (1991) 157-161
11. A receptor function. Pharmacol Biochem Behav 45 (1993) 423-428
12. A receptors. J Neuroendocrinol 7 (1995) 171-177
13. Blanchard R.J., McKittrick C.R., and Blanchard D.C. Animal models of social stress: effects on behaviour and brain neurochemical systems. Physiol Behav 73 (2001) 261-271
14. Bradley B.F., Starkey N.J., Brown S.L., and Lea R.W. Anxiolytic effects of Lavandula angustifolia odour on the Mongolian gerbil elevated plus maze. J Ethnopharmacol 111 (2007) 517-525
15. Bradley B.F., Starkey N.J., Brown S.L., and Lea R.W. The effects of prolonged rose odor inhalation in two animal models of anxiety. Physiol Behav 92 (2007) 931-938
16. Brain P.F. The laboratory gerbil. In: Poole T. (Ed). The UFAW handbook on the care and management of laboratory animals. 7th ed. (1999), Blackwell Science, Oxford 345-355
17. Brambilla F., Biggio G., Pisu M.G., Purdy R.H., Gerra G., Zaimovich A., et al. Plasma concentrations of anxiolytic neurosteroids in men with normal anxiety scores: a correlation analysis. Neuropsychobiol 50 (2004) 6-9
18. Brambilla F., Mellado C., Alciati A., Pisu M.G., Purdy R.H., Zanone S., et al. Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder. Psychiatry Res 135 (2005) 185-190
19. Bridges N.J., and Starkey N.J. Sex differences in Mongolian gerbils in four tests of anxiety. Physiol Behav 83 (2004) 119-127
20. Bridges NJ. Sex differences in the actions of psychoactive agents and progesterone on anxiety related behaviour in the Mongolian gerbil and the effects of corticosterone on the hippocampal morphology of wistar rats. PhD Thesis. UK: University of Central Lancashire; 2006.
21. 1A agonist 8-OH-DPAT in the social interaction test in gerbils. Brain Res 915 (2001) 170-175
22. Cloitre M., Yonkers K.A., Pearlstein T., Altemus M., Davidson K.W., Pigott T.A., et al. Women and anxiety disorders: implications for diagnosis and treatment. CNS Spectr 9 Suppl. 8 (2004) 1-16
23. Cole J.C., and Rodgers R.J. An ethological analysis of the effects of chlordiazepoxide and bretazenil (Ro 16-6082) in the murine elevated plus-maze. Behav Pharmacol 4 (1993) 573-580
24. Crawley J., and Goodwin F.K. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 13 (1980) 167-170
25. de Brito Faturi C., Teixeira-Silva F., and Leite J.R. The anxiolytic effect of pregnancy in rats is reversed by finasteride. Pharmacol Biochem Behav 85 (2006) 569-574
26. Dubrovsky B.O. Steroids, neuroactive steroids and neurosteroids in psychopathology. Prog. Neuro-Psychopharmacol Biol Psychiatry 29 (2005) 169-192
27. Dubrovsky B. Neurosteroids, neuroactive steroids, and symptoms of affective disorders. Pharmacol Biochem Behav 84 (2006) 644-655
28. Duffy R.A., Varty G.B., Morgan C.A., and Lachowicz J.E. Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioural effects of NK1 anatagonists. JPET 301 (2002) 536-542
29. Elwood R.W. Parental & maternal behaviour in the Mongolian gerbil. Anim Behav 23 (1975) 766-772
30. Engberg S., Ahlstedt I., Leffler A., Lindström E., Kristensson E., Svensson A., et al. Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors. Biochem Pharmacol 73 (2007) 259-269
31. Espejo E.F. Structure of mouse behaviour on the elevated plus-maze test of anxiety. Behav Brain Res 86 (1997) 105-112
32. Fenske M. Dissociation of plasma and urinary steroid values after application of stressors, insulin, vasopressin, ACTH, or dexamethasone in the Mongolian gerbil. Exp Clin Endocrinol Diabetes 104 6 (1996) 441-446
33. File S.E., Cheeta S., and Akanezi C. Diazepam and nicotine increase social interaction in gerbils: a test for anxiolytic action. Brain Res 888 (2001) 311-313
34. Finn D.A., Roberts A.J., Long S., Tanchuck M., and Phillips T.J. Neurosteroid consumption has anxiolytic effects in mice. Pharmacol Biochem Behav 76 (2003) 451-462
35. Frye C.A., Sumida K., Dudek B.C., Harney J.P., Lydon J.P., O'Malley, et al. Progesterone's effect to reduce anxiety behavior of aged mice do not require actions via intracellular progestin receptors. Psychopharmacology 186 (2006) 312-322
36. Frye C.A., Walf A.A., Rhodes M.E., and Harney J.P. Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behaviour of wild type mice, but not those deficient in type 1 5α-reductase. Brain Res 1004 (2004) 116-124
37. Galeeva A.Y., and Tuohimaa P. Analysis of mouse plus-maze behavior modulated by ovarian steroids. Behavioral Brain Res 119 (2001) 41-47
38. Galeeva A.Y., Tuohimaa P., and Shalyapina V.G. The role of sex steroids in forming anxiety states in female mice. Neurosci Behav Physiol 33 (2003) 415-420
39. Galeeva A.Y., Pivina S.G., Tuohimaa P., and Ordyan N.E. Involvement of nuclear progesterone receptors in the formation of anxiety in female mice. Neurosci Behav Physiol 37 8 (2007) 843-848
40. Gallo M.A., and Smith S.S. Progesterone withdrawal decreased latency to and increases duration of electrified prod burial: a possible rat model of PMS anxiety. Pharmacol Biochem Behav 46 (1993) 897-904
41. Gardiner K.A., Laming P.R., and Blumson N.L. Brain amino acid levels are related to seizure propensity in the gerbil (Meriones unguiculatus). Comp Biochem Physiol 106B (1993) 799-804
42. Gater R., Tansella M., Korten A., Tiemans B.G., Mavreas V.G., and Olatawura M.O. Sex differences in the prevalence and detection of depressive and anxiety disorders in general health care settings. Arch Gen Psychiat 55 (1998) 405-413
43. Gomez C., Saldivar-Gonzalez A., Delgado G., and Rodriguez R. Rapid anxiolytic activity of progesterone and pregnanolone in male rats. Pharmacol Biochem Behav 72 (2002) 543-550
44. A receptor subunit levels in association with increases anxiety in the female rat. Brain Res 910 (2001) 55-66
45. A receptor in male rats in association with anxiety and altered pharmacology-a comparison with female rats. Neuropharmacology 43 (2002) 701-714
46. A receptor pharmacology in adult rats. J Pharmacol Exp Therapeut 305 2 (2003) 541-548
47. Hascoët M., and Bourin M. A new approach to the light/dark test procedure in mice. Pharmacol Biochem Behav 60 (1998) 645-653
48. Henniger M.S.H., Ohl F., Hölter S.M., Weißenbacher P., Toschi N., Lörscher P., et al. Unconditioned anxiety and social behaviour in two rat lines selectively bred for high and low anxiety-related behaviour. Behav Brain Res 111 (2000) 153-163
49. Hiroi R., and Neumaier J.F. Differential effects of ovarian steroids on anxiety versus fear as measured by open field test and fear-potentiated startle. Behav Brain Res 166 (2006) 93-100
50. Holmes A., Parmigiani S., Ferrari P.F., Palanza P., and Rodgers R.J. Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol Behav 71 (2000) 509-516
51. Johnson NJT. CCK, neuroactive steroids and experimental anxiety: an ethopharmacological investigation. PhD Thesis. UK: University of Leeds; 1996.
52. Kanai Y., Araki T., Hiroyuki K., and Kogure K. Autoradiographic distribution of neurotransmitter and second messenger system receptors in animal brains. Behav Brain Res 65 (1994) 67-73
53. Kaplan H. What triggers seizures in the gerbil. Meriones unguiculatus?. Life Sci 17 (1975) 693-698
54. A receptors. Prog Neurobiol 71 (2003) 67-80
55. Lapiz M.D.S., and Hogg S. Behavioural response of gerbils to anxiolytics and antidepressants in the light and dark test. Neuropsychopharmacol 12 (2002) S338
56. Leffler A., Ahlstedt I., Engberg S., Svensson A., Billger M., Öberg L., et al. Characterization of species related differences in the pharmacology of tachykinin NK1 receptors 1, 2 and 3. Biochem Pharmacol 77 (2009) 1522-1530
57. Little H.J. The benzodiazepines: anxiolytic and withdrawal effects. Neuropetides 19 (1991) 11-14
58. Löfgren M., Johansson I.-M., Meyerson B., Lundgren P., and Bäckström T. Progesterone withdrawal effects in the open field test can be predicted by elevated plus-maze performance. Horm Behav 50 (2006) 208-215
59. Longone P., Rupprecht R., Manieri G.A., Bernardi G., Romeo E., and Pasini A. The complex roles of neurosteroids in depression and anxiety disorders. Neurochem Int 52 (2008) 596-601
60. Martínez J.C., Cardenas F., Lamprea M., and Morato S. The role of vision and proprioception in the aversion of rats to the open arms of an elevated plus-maze. Behav Proc 60 (2002) 15-26
61. McEwan B.S., Coirini H., and Schumacher M. Steroid effects on neuronal activity: when is the genome involved?. Steroids and Neuronal Activity. Ciba Foundation Symposium, vol. 153 (1990), John Wiley & Sons, Chichester 3-21
62. Mellon S.H., Griffin L.D., and Compagnone N.A. Biosynthesis and action of neurosteroids. Brain Res Rev 37 (2001) 3-12
63. A receptors: molecular determinants and significance in health and disease. Neurochem Int 52 (2008) 588-595
64. Mora S., Dussaubat N., and Díaz-Véliz G. Effects of the estrous cycles and ovarian hormones on behavioral indices of anxiety in female rats. Psychoneuroendocrinology 21 (1996) 609-620
65. A receptors and anxiety: from neurobiology to treatment (1995), Paven Press, New York 57-74
66. Pellow S., Chopin P., File S.E., and Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14 (1985) 149-167
67. Pigott T.A. Gender differences in the epidemiology and treatment of anxiety disorders. J Clin Psychiatry 60 (1999) 4-15
68. Pigott T.A. Anxiety disorders in women. Psychiatr Clin North Am 26 (2003) 621-672
69. Reddy D.S., O'Malley B.W., and Rogawski M.A. Anxiolytic activity of progesterone in progesterone receptor knockout mice. Neuropharmacology 48 (2005) 14-24
70. Revilla V., Robles M.S., Bermejo J.C., Paniagua M.A., and Fernández- LÓpez A. Seizure refractory period after a single stimulation and inhibition of seizures after repetitive stimulation in the gerbil: effects on blood cortisol. Epilepsia 40 1 (1999) 1-4
71. Rodgers R.J., and Johnson N.J.T. Behaviorally selective effects of neuroactive steroids on plus-maze anxiety in mice. Pharmacol Biochem Behav 59 (1998) 221-232
72. Rupprecht R. The neuropsychopharmacological potential of neuroactive steroids. J Psychiatr Res 31 (1997) 297-314
73. Rupprecht R. Neuroactive steroids: mechanisms of action and neuropsychopharmacological properties. Psychoneuroendocrinology 28 (2003) 139-168
74. Rupprecht R., di Michele F., Hermann B., Ströhle A., Lancal M., Romeo E., et al. Neuroactive steroids: molecular mechanisms of action and implications for neuropsychopharmacology. Brain Res Rev 37 (2001) 59-67
75. Saavedra M., Contreras C.M., Azamar-Arizmendi G., and Hernández-Lozano M. Differential progesterone effects on defensive burying and forced swimming tests depend upon a gradual decrease or an abrupt suppression schedules. Pharmacol Biochem Behav 83 (2006) 130-135
76. Shimozuru M., Kikusui T., Takeuchi Y., and Mori Y. Effects of isolation-rearing on the development of social behaviours in male Mongolian gerbils (Meriones unguicalatus). Physiol Behav 94 (2008) 491-500
77. A receptor gene regulation in the brain and anxiety behavior. Steroids 67 (2002) 519-528
78. Spangler E.L., Hengemihle J., Blacnk G., Speer D.L., Brzozowski S., Patel N., et al. An assessment of behavioural aging in the Mongolian gerbil. Exp Geront 32 (1997) 707-717
79. Starkey N.J., Normington G., and Bridges N.J. The effects of individual housing on 'anxious' behaviour in male and female gerbils. Physiol Behav 90 (2007) 545-552
80. Tabachnick B.G., and Fidell L.S. Using multivariate statistics. 3rd ed. (2001), Allyn & Bacon, Boston
81. Timothy C., Costall B., and Smythe J.W. Effects of SCH23390 and raclopride on anxiety-like behavior in rats tested in the black-white box. Pharmacol Biochem Behav 62 (1999) 323-327
82. Varty G.B., Morgan C.A., Cohen-Williams M.E., Coffin V.L., and Carey G.J. The gerbil elevated plus-maze I: behavioural characterization and pharmacological validation. Neuropsychopharmacology 27 (2002) 357-370
83. Weinart D., Weinandy R., and Gattermann R. Photic and non-photic effects on the daily activity pattern of Mongolian gerbils. Physiol Behav 90 (2007) 325-333
84. Wieland S., Belluzzi J.D., Stein L., and Lan N.C. Comparative behavioural characterisation of the neuroactive steroids 3-alpha-OH,5-alpha-pregnan-20-one and 3-alpha,5-beta-pregnan-20-one in rodents. Psychopharmacology 118 (1995) 65-71
85. Wieland S., Lan N.C., Mirasedeghi S., and Gee K.W. Anxiolytic activity of the progesterone metabolite 5α-pregnan-3α-ol-20-one. Brain Res 565 (1991) 262-268
86. Yonkers K.A., and Gurguis G. Gender differences in the prevalence and expression of anxiety disorders. In: Seeman M.V. (Ed). Gender and psychopathology (1995), American Psychiatric Press, Washington, DC 113-130
87. Zuluaga M.J., Agrat D., Pereira M., Uriarte N., Fernández-Guasti A., and Ferreira A. Experimental anxiety in the black and white model in cycling, pregnant and lactating rats. Physiol Behav 84 (2005) 279-286